PTGX: Protagonist Therapeutics, Inc.
Performance
PTGX +70.86%
Watchlist
Select an item
Summary
PTGX at a glance
PTGX returned +70.86% over the past year and +32.03% a year over five years. Its worst drop in that year was -18.83%, smaller than 82% of stocks on Redstone, and its Sharpe ratio of 1.44 beats 90% of stocks on Redstone. It pays no dividends.
Current Drawdown
-14.32%
Rolling Volatility
42.93%
Actions
Metrics
Risk Indicators
Alpha48.86%
Beta0.95x
Sharpe1.44
Sortino2.29
Omega1.27
Calmar3.76
Martin7.44
Profile
About PTGX
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $8.8B
- Listed
- Aug 2016
- Employees
- 141
- Headquarters
- Newark, CA
- Website
- protagonist-inc.com
Comparisons